Cargando…

Comparative Effectiveness of Proton Therapy versus Photon Radiotherapy in Adolescents and Young Adults for Classical Hodgkin Lymphoma

PURPOSE: Early stage (stages I-II) classical Hodgkin lymphoma (cHL) is a highly curable disease typically diagnosed in adolescents and young adults (AYAs). Proton therapy can also reduce the late toxicity burden in this population, but data on its comparative efficacy with photon radiotherapy in thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bates, James E., Terezakis, Stephanie, Morris, Christopher G., Rao, Avani D., Sehgal, Shuchi, Kumar, Rahul, Mailhot Vega, Raymond B., Mendenhall, Nancy P., Hoppe, Bradford S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Particle Therapy Co-operative Group 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8768899/ https://www.ncbi.nlm.nih.gov/pubmed/35127972 http://dx.doi.org/10.14338/IJPT-21-00011.1

Ejemplares similares

Irradiating Residual Disease to 30 Gy with Proton Therapy in Pediatric Mediastinal Hodgkin Lymphoma
por: Hoppe, Bradford S., et al.
Publicado: (2020)

Proton therapy in the management of non-Hodgkin lymphoma
por: Sachsman, Suzanne, et al.
Publicado: (2015)

Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma
por: Way, Ashley, et al.
Publicado: (2021)

Pulmonary Function after Proton Therapy for Hodgkin Lymphoma
por: O'steen, Lillie, et al.
Publicado: (2019)

Postoperative or Salvage Proton Radiotherapy for Prostate Cancer After Radical Prostatectomy
por: Kharod, Shivam M., et al.
Publicado: (2021)

Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression
por: Kil, Whoon Jong, et al.
Publicado: (2013)

Dosimetric consequences of image guidance techniques on robust optimized intensity-modulated proton therapy for treatment of breast Cancer
por: Liang, Xiaoying, et al.
Publicado: (2020)

Proton Radiation Therapy After Chemotherapy in the Management of Aggressive Mediastinal Non-Hodgkin Lymphomas: A Particle Therapy Cooperative Group Lymphoma Subcommittee Collaboration
por: Baron, Jonathan A., et al.
Publicado: (2022)

Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma
por: Mailhot Vega, Raymond B., et al.
Publicado: (2021)

Importance of baseline PET/CT imaging on radiation field design and relapse rates in patients with Hodgkin lymphoma
por: Figura, Nick, et al.
Publicado: (2017)

Does the Incidence of Treatment-Related Toxicity Plateau After Radiation Therapy: The Long-Term Impact of Integral Dose in Hodgkin's Lymphoma Survivors
por: Holtzman, Adam L., et al.
Publicado: (2019)

RBE‐weighted dose and its impact on the risk of acute coronary event for breast cancer patients treated with intensity modulated proton therapy
por: Liu, Chunbo, et al.
Publicado: (2022)

Incidence of Rib Fracture following Treatment with Proton Therapy for Breast Cancer
por: Bradley, Julie A., et al.
Publicado: (2023)

Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma
por: Hoppe, B. S., et al.
Publicado: (2017)

RONC-22. SECOND TUMORS IN PEDIATRIC PATIENTS TREATED WITH PROTON THERAPY TO THE CENTRAL NERVOUS SYSTEM
por: Indelicato, Daniel J, et al.
Publicado: (2020)

Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer?
por: Bryant, Curtis, et al.
Publicado: (2016)

Radiation Therapy Across Pediatric Hodgkin Lymphoma Research Group Protocols: A Report From the Staging, Evaluation, and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent, and Young Adult Hodgkin Lymphoma (CAYAHL) Group
por: Hall, Matthew D., et al.
Publicado: (2022)

Proton Therapy for Bilateral Breast Cancer Maximizes Normal-Tissue Sparing
por: Brooks, Eric D., et al.
Publicado: (2023)

Erectile Function, Incontinence, and Other Quality of Life Outcomes Following Proton Therapy for Prostate Cancer in Men 60 Years Old and Younger
por: Hoppe, Bradford S, et al.
Publicado: (2012)

Intrafractional Displacement of Cardiac Substructures Among Patients With Mediastinal Lymphoma or Lung Cancer
por: Guzhva, Lidia, et al.
Publicado: (2019)

Hyperfractionated-Accelerated Reirradiation with Proton Therapy for Radiation-Associated Breast Angiosarcoma
por: Looi, Wen Shen, et al.
Publicado: (2022)

Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: Results of two prospective trials
por: Henderson, Randal H., et al.
Publicado: (2013)

Advantage of proton-radiotherapy for pediatric patients and adolescents with Hodgkin’s disease
por: Lautenschlaeger, S., et al.
Publicado: (2019)

Radiation Therapy for Primary Adenoid Cystic Carcinoma of the Trachea: Photons, Protons, or Carbon
por: Tun, Alexander J., et al.
Publicado: (2023)

Concomitant Radiation Recall Dermatitis and Organizing Pneumonia following Breast Radiotherapy: A Case Report
por: Liu, I-Chia, et al.
Publicado: (2020)

RONC-24. PROTON THERAPY FOR PEDIATRIC EPENDYMOMA: MATURE OUTCOMES FROM THE UNIVERSITY OF FLORIDA AND MASSACHUSETTS GENERAL HOSPITAL
por: Indelicato, Daniel J, et al.
Publicado: (2020)

Genetics of classical Hodgkin Lymphoma
por: Schiavoni, Gianluca, et al.
Publicado: (2018)

RONC-03. Secondary Neoplasms in Children with Central Nervous System (CNS) Tumors Following Radiotherapy in the Modern Era
por: Indelicato, Daniel, et al.
Publicado: (2022)

Resources-Stratified Guidelines for Classical Hodgkin Lymphoma
por: Relecom, Allan, et al.
Publicado: (2020)

What men want: Results from a national survey on decision making for prostate cancer treatment and research participation
por: Mendenhall, Nancy P., et al.
Publicado: (2021)

Consensus Statement on Proton Therapy for Prostate Cancer
por: Bryant, Curtis M., et al.
Publicado: (2021)

Dosimetric characterization of whole brain radiotherapy of pediatric patients using modulated proton beams
por: Jin, Hosang, et al.
Publicado: (2011)

The molecular mechanisms of classic Hodgkin's lymphoma.
por: Felberbaum, Rachael S.
Publicado: (2005)

Immunological Deregulation in Classic Hodgkin Lymphoma
por: Romano, Alessandra, et al.
Publicado: (2014)

Controversies in the Treatment of Classical Hodgkin Lymphoma
por: Eichenauer, Dennis A., et al.
Publicado: (2018)

The Grey Zones of Classic Hodgkin Lymphoma
por: Bosch-Schips, Jan, et al.
Publicado: (2022)

A Rare Case of Classical Hodgkin Lymphoma of the Thyroid Gland
por: Chandran, Chandriya, et al.
Publicado: (2021)

Racial and Ethnic Demographic Reporting in Phase 2 Proton Therapy Clinical Trials: A Review
por: Fakhry, Jonathan S., et al.
Publicado: (2023)

The real risk of secondary non-Hodgkin lymphoma following classical Hodgkin lymphoma
por: Dogan, Ahmet
Publicado: (2022)

Bob-1 is expressed in classic Hodgkin lymphoma
por: Abd El All, Howayda S
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_l4mfehll1og17bsat0f19pcn94